1. Home
  2. FTRE vs WTW Comparison

FTRE vs WTW Comparison

Compare FTRE & WTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRE
  • WTW
  • Stock Information
  • Founded
  • FTRE 1996
  • WTW 1828
  • Country
  • FTRE United States
  • WTW United Kingdom
  • Employees
  • FTRE N/A
  • WTW N/A
  • Industry
  • FTRE Medical Specialities
  • WTW Specialty Insurers
  • Sector
  • FTRE Health Care
  • WTW Finance
  • Exchange
  • FTRE Nasdaq
  • WTW Nasdaq
  • Market Cap
  • FTRE 469.0M
  • WTW 32.3B
  • IPO Year
  • FTRE N/A
  • WTW N/A
  • Fundamental
  • Price
  • FTRE $5.95
  • WTW $309.17
  • Analyst Decision
  • FTRE Hold
  • WTW Buy
  • Analyst Count
  • FTRE 11
  • WTW 12
  • Target Price
  • FTRE $18.00
  • WTW $343.33
  • AVG Volume (30 Days)
  • FTRE 2.3M
  • WTW 735.7K
  • Earning Date
  • FTRE 05-12-2025
  • WTW 04-24-2025
  • Dividend Yield
  • FTRE N/A
  • WTW 1.19%
  • EPS Growth
  • FTRE N/A
  • WTW N/A
  • EPS
  • FTRE N/A
  • WTW N/A
  • Revenue
  • FTRE $2,696,400,000.00
  • WTW $9,812,000,000.00
  • Revenue This Year
  • FTRE N/A
  • WTW N/A
  • Revenue Next Year
  • FTRE $3.32
  • WTW $5.96
  • P/E Ratio
  • FTRE N/A
  • WTW N/A
  • Revenue Growth
  • FTRE N/A
  • WTW 2.42
  • 52 Week Low
  • FTRE $4.77
  • WTW $248.09
  • 52 Week High
  • FTRE $37.24
  • WTW $344.14
  • Technical
  • Relative Strength Index (RSI)
  • FTRE 43.28
  • WTW 44.57
  • Support Level
  • FTRE $5.40
  • WTW $303.92
  • Resistance Level
  • FTRE $6.38
  • WTW $312.93
  • Average True Range (ATR)
  • FTRE 0.45
  • WTW 7.47
  • MACD
  • FTRE 0.21
  • WTW 0.09
  • Stochastic Oscillator
  • FTRE 72.52
  • WTW 45.05

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

About WTW Willis Towers Watson Public Limited Company

Willis Towers Watson PLC is an advisory, broking, and solutions company that provides data-driven, insight-led solutions in the areas of people, risk, and capital. The company's segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, broking, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and employee experience overall. It focuses on four key areas: Health, Wealth, Career and Benefits Delivery & Outsourcing. The R&B segment provides risk advice, insurance brokerage and consulting services to clients ranging from small businesses to multinational corporations. Its R&B segment includes two businesses: Corporate Risk & Broking and Insurance Consulting and Technology.

Share on Social Networks: